A new study reinforces the idea that there are similarities between psychedelics and meditation, with participants who had ...

A psychedelic trip that leaves one person feeling transformed could leave another feeling unsettled — and personality may be ...

When it comes to treating stuttering in speech, it may be worthwhile to utilize psychedelic substances, such as psilocybin ...

A recent study published in Translational Psychiatry sheds new light on the diverse factors that influence how individuals experience the effects of LSD (lysergic acid diethylamide). The research ...

A new study has shed light on the complex changes in brain connectivity induced by LSD, MDMA and d-amphetamine. These compounds share overlapping effects on neurotransmitter systems, influencing ...

A groundbreaking new survey is shedding light on how people with eating disorders are turning to alternative ...

The mind-expanding drugs may help heal many mental health conditions. But studies haven’t actually proved that yet.

Mind Medicine has commenced its Phase 3 Voyage study, dosing the first patient with MM120, an optimized form of LSD, for treating Generalized Anxiety Disorder (GAD). This study aims to assess the ...

In early 2022 the FDA cleared an IND, which in turn cleared a clinical hold and allowed the first LSD study in decades. MindMed later engaged in a Phase 2 study involving single doses of 25 mg, 50 ...

The LSD study has been funded so far with 100,000 pounds from the Beckley Foundation, a UK-based think tank dedicated to researching potential medical benefits of psychoactive substances.

Mind Medicine has commenced its Phase 3 Voyage study, dosing the first patient with MM120, an optimized form of LSD, for treating Generalized Anxiety Disorder (GAD).